23 May 2013
Keywords: Alcon, Novartis, Nevanac, Macular edema, Scotland, SMC, Catarct surgery
Article | 12 November 2012
Ophthalmic specialist Alcon, a part of Swiss drug major Novartis (NOVN: VX), said yesterday that its Nevanac (nepafenac) 1mg/ml, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 November 2012
5 November 2012
19 November 2012
© 2013 thepharmaletter.com